Mirae Asset Global Etfs Holdings Ltd. Fate Therapeutics Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 63,264 shares of FATE stock, worth $106,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,264
Previous 51,744
22.26%
Holding current value
$106,283
Previous $169,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FATE
# of Institutions
175Shares Held
115MCall Options Held
53.7KPut Options Held
9K-
Redmile Group, LLC San Francisco, CA13.2MShares$22.1 Million3.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$17.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$17 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$9.36 Million0.72% of portfolio
-
State Street Corp Boston, MA5.25MShares$8.82 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $163M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...